SELENOP and familial pancreatic carcinoma: Although to our knowledge, no studies indicate the expression of SeP in chemotherapy treated pancreatic cancer, in line with our findings of reduced SeP expression in macrophages under the influence of FOLFIRINOX treatment and CAFs, a study found a markedly diminished expression of SeP in the plasma of cervical cancer patients resistant to chemoradiotherapy [34].